OpenFilings
Citius Pharmaceuticals, Inc.
Form
8-K
Report Period
2025-04-16
Date Filed
2025-04-18
Time Filed
16:05:37
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
CURRENT REPORT
CERTIFICATE OF DESIGNATION OF SERIES A PREFERRED STOCK
AMENDMENT TO THE AMENDED AND RESTATED BYLAWS OF CITIUS PHARMACEUTICALS, INC
SUBSCRIPTION AND INVESTMENT REPRESENTATION AGREEMENT, DATED APRIL 17, 2025, BY A
Filing on SEC Edgar